CDKN2A and angiosarcoma: Abnormalities in the TP53 pathway – including p53 mutations, Mdm-2 overexpression and inactivation of p14ARF – are common molecular aberrations in angiosarcoma (Hollstein et al., 1994; Zietz et al., 1998; Weihrauch et al., 2002).